Biotech
Foundation Medicine
Foundation Medicine raises $100M Series D at $1B valuation
Cambridge, MAMarch 31, 20151 min read
Total Raised
$100M
Valuation
$1B
Latest Round
Series D
Employees
1000+
Foundation Medicine: Series D Funding Round
Foundation Medicine has successfully raised $100M in Series D funding, reaching a valuation of $1B.
Company Overview
Genomic profiling for cancer treatment
Funding Details
The Series D round was led by Third Rock Ventures, with participation from Google Ventures.
Company Information
- Headquarters: Cambridge, MA
- Founded: 2010
- Employees: 1000+
- Category: Biotech
Investment
Foundation Medicine plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Third Rock Ventures: Verified investor in Series D
- Google Ventures: Verified investor in Series D
Company Info
Headquarters
Cambridge, MA
Founded
2010
Team Size
1000+
Last Round
$100M(Mar 2015)
Investors (2)
T
Third Rock VenturesLeadLead Investor
Verified investor in Series D
G
Google VenturesInvestor
Verified investor in Series D
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free